New Version of EDC Solution Builds on Web Capabilities for Integration and Study Deployment
New Version of EDC Solution Builds on Web Capabilities for Integration and Study Deployment
etrials Worldwide (Morrisville, NC) has released EDC 2.0, the latest version of its software for pharmaceutical companies used to collect, manage, and analyze clinical trial information.
EDC 2.0 is Web-based and can integrate with etrials eDiary and IVR solutions to provide a more comprehensive e-clinical solution.
Also, because it is Web-based, it can be accessed by study sites and provides user-directed functions and design. The product also includes new reporting and configuration capabilities. Other functions include Electronic Case Report Forms (eCRF), workflow manager, a Message/Alert manager that uses a message center to connect and communicate with sites and investigators, a Reporting/Analytics function, and a Design Manager to improve application interfaces for increased user function.
Data is housed in a single data repository and includes the ability to integrate study-related data using Data Xchange.
etrials Worldwide, (919) 653-3400, www.etrials.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.